Literature DB >> 2315994

Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolitica.

M A Tipple1, L A Bland, J J Murphy, M J Arduino, A L Panlilio, J J Farmer, M A Tourault, C R Macpherson, J E Menitove, A J Grindon.   

Abstract

Between April 1987 and May 1989, the Centers for Disease Control investigated seven cases of transfusion-associated Yersinia enterocolitica sepsis; four were caused by organisms of serotype O:3, and one each was caused by organisms of serotype O:1,2,3; O:5,27; and O:20. All seven recipients developed septic shock after receiving units of red cells (RBCs) contaminated with Y. enterocolitica; five recipients died. The cases occurred in seven states and were unrelated. There was no evidence for contamination of the RBC units during processing. Six of the seven donors had serologic evidence of recent Y. enterocolitica infection, and it is hypothesized that these donors had asymptomatic bacteremia when they donated the implicated blood. Four of the seven donors reported gastrointestinal illness in the 4 weeks before blood donation, and one donor became ill on the day he donated blood. Y. enterocolitica grows well at 4 degrees C and in the presence of dextrose and iron. If blood is contaminated at the time of collection, storage of the RBCs at 4 degrees C provides an ideal environment for bacterial growth and endotoxin production. These cases demonstrate the need for careful evaluation of patients with transfusion reactions for possible sepsis and suggest a need to screen prospective blood donors for mild gastrointestinal illness, including those illnesses not requiring physician evaluation or medication.

Entities:  

Mesh:

Year:  1990        PMID: 2315994     DOI: 10.1046/j.1537-2995.1990.30390194338.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  17 in total

1.  Transfusing Yersinia enterocolitica.

Authors:  M Prentice
Journal:  BMJ       Date:  1992-09-19

Review 2.  Bacterial contamination of blood components.

Authors:  Mark E Brecher; Shauna N Hay
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

Review 3.  Epidemiology of human listeriosis.

Authors:  A Schuchat; B Swaminathan; C V Broome
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

4.  Molecular epidemiology of Yersinia enterocolitica O:3 infections: use of chromosomal DNA restriction fragment length polymorphisms of rRNA genes.

Authors:  H M Blumberg; J A Kiehlbauch; I K Wachsmuth
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

5.  Failure to kill Yersinia enterocolitica by plasma diluted to the concentration found in red cell units.

Authors:  A P Gibb; N Poling; W G Murphy
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

6.  Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor XI, during defense against the gram-negative bacterium Yersinia enterocolitica.

Authors:  Deyan Luo; Frank M Szaba; Lawrence W Kummer; Edward F Plow; Nigel Mackman; David Gailani; Stephen T Smiley
Journal:  J Immunol       Date:  2011-07-01       Impact factor: 5.422

Review 7.  Yersinia enterocolitica: the charisma continues.

Authors:  E J Bottone
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

8.  Yersinia enterocolitica septicaemia from transfusion of red cell concentrate stored for 16 days.

Authors:  B L Jones; M H Saw; M F Hanson; M J Mackie; J Scott; W G Murphy
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

9.  Post transfusion septicaemia 1980-1989: importance of donor arm cleansing.

Authors:  A Puckett; G Davison; C C Entwistle; J A Barbara
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

10.  Patient cytokine response in transfusion-associated sepsis.

Authors:  S K McAllister; L A Bland; M J Arduino; S M Aguero; P N Wenger; W R Jarvis
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.